Back to results

Chemistry

Platinum Complexes With Tridentate Ligands as Models for Active Monofunctional Anticancer Drugs

Abstract

dc:description.abstract

<p>Pt(II) complexes bind preferentially at N7 of G residues of DNA, causing DNA structural distortions associated with anticancer activity. Some distortions induced by difunctional cisplatin are also found for monofunctional Pt(II) complexes with carrier ligands having bulk projecting toward the guanine base. This ligand bulk can be correlated with impeded rotation about the Pt–N7(guanine) bond. The objective of this study is to understand the influences of in-plane bulk of Pt(Ltri)G adducts (Ltri = tridentate carrier ligand, G = guanine derivative bound to a metal, but not tethered to another nucleobase). NMR spectroscopy provided conclusive evidence that Pt(Ltri)G (Ltri = di-(2-picolyl)amine (N(H)dpa), N-(6-methyl-2-picolyl)-N-(2-picolyl)amine (N(H)6-Medpa), di-(6-methyl-2-picolyl)amine (N(H)6,6′-Me2dpa), N-(6-methyl-2-picolyl)-N-(2-picolyl)amine (N(H)6,6′-Me2dpa), N(Me)-di-(6-methyl-2-picolyl)amine (N(Me)6,6′-Me2dpa), N(propionoic acid)-di-(6-methyl-2-picolyl)amine (N(prop)6,6′-Me2dpa), and tri-(6-methyl-2-picolyl)amine (6,6′,6′′-Me3tpa)) adducts exist as interconverting mixtures of syn and anti rotamers from the observation of two sharp, comparably intense guanine H8 NMR signals. Rotational interchange is impeded by Ltri, and the key interactions involved steric repulsions between the pyridyl and guanine rings. When G is added to [Pt(N(H)6,6′-Me2dpa)Cl]Cl, the expected Pt(N(H)6,6′-Me2dpa)G mono adduct forms having syn and anti conformers, but also the Pt(N(H)6,6′-Me2dpa)G2 bis adducts consisting of ΛHT and ΔHT conformers (HT = head-to-tail). When G is added to Pt(N(R)6,6′-Me2dpa)G adducts, the transformation of the bis adducts Pt(N(R)6,6′-Me2dpa)G2 are dramatically lessened, particularly when the bulk of the R group is increased. The stability of the Pt(N(R)6,6′-Me2dpa)G mono adducts are explained by the increased bulk of the N-substituent, making the bidentate coordination mode of the carrier ligand unfavorable.</p>

Degree

thesis:*
Name thesis:degree_name
Doctor of Philosophy (PhD)
Level thesis:degree_level
Dissertation
Discipline thesis:degree_discipline
Chemistry
Grantor
Chemistry
Year dc:date.available
2015

Author and committee

dc:creator, dc:contributor.*
Author dc:creator
  • Andrepont, Chase Koby

Subjects

dc:subject × 3

Rights

dc:rights
Statement dc:rights
  • withheld
  • Secure the entire work for patent and/or proprietary purposes for a period of one year. Student has submitted appropriate documentation which states: During this period the copyright owner also agrees not to exercise her/his ownership rights, including public use in works, without prior authorization from LSU. At the end of the one year period, either we or LSU may request an automatic extension for one additional year. At the end of the one year secure period (or its extension, if such is requested), the work will be released for access worldwide.

Identifiers

dc:identifier.*
OAI identifier oai:identifier
oai:repository.lsu.edu:gradschool_dissertations-2442

Chain of custody

source
Harvested from
Lousiana State University
Base URL
repository.lsu.edu/do/oai/
Last updated
2026-07-24
Source record
OAI-PMH GetRecord
citation

Andrepont, Chase Koby. Platinum Complexes With Tridentate Ligands as Models for Active Monofunctional Anticancer Drugs. Dissertation thesis, Chemistry, 2015. https://doi.org/10.31390/gradschool_dissertations.1443